Clinical study of gemcitabine plus docetaxel in patient with refractory bone and soft tissue sarcomas
Phase 2
- Conditions
- bone and soft tissue sarcoma
- Registration Number
- JPRN-UMIN000017967
- Lead Sponsor
- Juntendo University Urayasu Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with severe liver or renal dysfunction Patient with severe interstitial pneumonitis PS4 Pregnant woman Patient who was decided as incompatible by the principal investigator of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method tumor response survival
- Secondary Outcome Measures
Name Time Method